WallStSmart

Huntsman Corporation (HUN)vsREX American Resources Corporation (REX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Huntsman Corporation generates 768% more annual revenue ($5.69B vs $656.20M). REX leads profitability with a 14.1% profit margin vs -5.8%. REX appears more attractively valued with a PEG of 1.74. REX earns a higher WallStSmart Score of 61/100 (C+).

HUN

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 2.0Value: 3.7Quality: 4.5
Piotroski: 1/9Altman Z: 1.67

REX

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 6.0Value: 6.7Quality: 9.0
Piotroski: 4/9Altman Z: 7.10
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HUNSignificantly Overvalued (-22.6%)

Margin of Safety

-22.6%

Fair Value

$11.47

Current Price

$14.21

$2.74 premium

UndervaluedFair: $11.47Overvalued
REXUndervalued (+24.3%)

Margin of Safety

+24.3%

Fair Value

$47.11

Current Price

$44.92

$2.19 discount

UndervaluedFair: $47.11Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HUN2 strengths · Avg: 9.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

EPS GrowthGrowth
20.6%8/10

Earnings expanding 20.6% YoY

REX5 strengths · Avg: 9.2/10
EPS GrowthGrowth
118.5%10/10

Earnings expanding 118.5% YoY

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.1010/10

Safe zone — low bankruptcy risk

P/E RatioValuation
16.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

HUN4 concerns · Avg: 3.8/10
PEG RatioValuation
2.224/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.7%4/10

0.7% revenue growth

Altman Z-ScoreHealth
1.674/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

REX4 concerns · Avg: 3.3/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.6%4/10

3.6% revenue growth

Market CapQuality
$1.54B3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-13.73M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : HUN

The strongest argument for HUN centers on Price/Book, EPS Growth.

Bull Case : REX

The strongest argument for REX centers on EPS Growth, Debt/Equity, Altman Z-Score.

Bear Case : HUN

The primary concerns for HUN are PEG Ratio, Revenue Growth, Altman Z-Score.

Bear Case : REX

The primary concerns for REX are PEG Ratio, Revenue Growth, Market Cap.

Key Dynamics to Monitor

HUN profiles as a turnaround stock while REX is a value play — different risk/reward profiles.

HUN carries more volatility with a beta of 0.64 — expect wider price swings.

REX is growing revenue faster at 3.6% — sustainability is the question.

REX generates stronger free cash flow (-14M), providing more financial flexibility.

Bottom Line

REX scores higher overall (61/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Huntsman Corporation

BASIC MATERIALS · CHEMICALS · USA

Huntsman Corporation manufactures and sells differentiated organic chemicals globally. The company is headquartered in The Woodlands, Texas.

Visit Website →

REX American Resources Corporation

BASIC MATERIALS · CHEMICALS · USA

REX American Resources Corporation, produces and sells ethanol in the United States. The company is headquartered in Dayton, Ohio.

Visit Website →

Want to dig deeper into these stocks?